Interventions for morphea
Referencias
Additional references
Alderson P, Green S, Higgins JPT (eds). Cochrane Reviewers’ Handbook 4.2.1 [updated December 2003]. The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons Ltd, 2004.
Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium‐dose UVA1 phototherapy in localized scleroderma and its effect in CD34‐positive dendritic cells. Journal of the American Academy of Dermatology 1998;38(1):21‐6. [MedLine: 11606918].
Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea linear scleroderma. Journal of the American Academy of Dermatology 1998;39(2):211‐5. [MedLine: 9704831].
Eisen D, Alster T. Use of a 585 pulsed dye laser for the treatment of morphea. Derm Surg 2002;28(7):615‐6. [MedLine: 12135520].
Falanga V, Medsger TA, Reichlin M, Rodnan GP. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Annals of Internal Medicine 1986;104(6):849‐57. [MedLine: 3486617].
Falaga V, Medsger TA. D‐Penicillamine in the treatment of localized scleroderma. Archives of Dermatology 1990;126(5):609‐12. [MedLine: 2334179].
Fujiwara H, Fujiwara K, Hashimoto K, Mehregan AH, Schaumburg‐Lever G, Lange R, et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Archives of Dermatology 1997;133(1):41‐4. [MedLine: 9006371].
Grundmann‐Kollmann M, Ochsendorf F, Zollner TM, Spieth K, Sachsenberg‐Struder E, Kauffmann R, et al. PUVA‐cream phototherapy for the treatment of localized scleroderma. Journal of the American Academy of Dermatology 2000;43(4):675‐8. [MedLine: 11004625].
Harrington CI, Dunsmore IR. An investigation into the incidence of auto‐immune disorders in patients with localized morphea. British Journal of Dermatology 1989;120(5):645‐8. [MedLine: 2757929].
Hoffmann K, Gerbaulet U, el‐Gammal S, Altmeyer P. 20 MHz B‐mode ultrasound in monitoring the course of localized scleroderma (morphea). Acta dermato‐venerologica Supplementum 1991;164:3‐16. [MedLine: 1812687].
Hulshof MM, Pavel S, Breedveld FC, Dijkmans BA, Vermeer BJ. Oral calcitriol as a new therapeutic modality for generalized morphea. Archives of Dermatology 1994;130(10):1290‐3. [MedLine: 7944511].
Humbert P, Dupond JL, Rochefort A, Vasselet R, Lucas A, Laurent R, et al. Localized scleroderma: response to 1,25‐dihydroxyvitamin. Clinical Experimental Dermatology 1990;15(5):396‐8. [MedLine: 2225549].
Humbert P, Aubin F, Dupond JL, Delaporte E. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma. Archives of Dermatology 1995;131(7):850‐1. [MedLine: 7611809].
Hunzelmann N, Anders S, Fierlbeck G, Hein R, Herrmann K, Albrecht M, et al. Double‐blind, placebo‐controlled study of intralesional interferon gamma for the treatment of localized scleroderma. Journal of the American Academy of Dermatology 1997;36:433‐5. [MedLine: 9091475].
Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow‐up study on 17 patients. Archives of Dermatology 1994;130(5):663‐4. [MedLine: 8179352].
Karrer S, Abels C, Landthaler M, Sziemies RM. Topical photodynamic therapy for localized scleroderma. Acta Dermato‐Venereologica 2000;80:26‐7. [MedLine: 10721828].
Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. Low‐dose UVA phototherapy for treatment of localized scleroderma. Journal of the American Academy of Dermatology 1998;38(1):21‐6. [MedLine: 9448200].
Koeger AC, Rozenberg S, Fautrel B. Effectiveness of topical calcitriol for localized scleroderma. Journal of Rheumatology 1999;26(10):239‐40. [MedLine: 9918276].
Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffman M, Hoffman K, et al. Combined treatment with calcipotril ointment and low‐dose ultraviolet A1 phototherapy in childhood morphea. Pediatric Dermatology 2001;18(3):241‐5. [MedLine: 11438008].
Littman BH. Linear scleroderma: a response to neurologic injury? Report and literature review. Journal of Rheumatology 1989;16(8):1135‐40. [MedLine: 2685298].
Mohrenschlager M, Jung C, Ring J, Abeck D. Effect of penicillin G on corium thickness in linear morphea of childhood: An analysis using ultrasound technique. Pediatric Dermatology 1999;16(4):314‐6. [MedLine: 10469421].
Ozkan S, Atabey N, Fetil E, Erkizan V, Gunes AT. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. International Journal of Dermatology 2000;39(4):278‐83. [MedLine: 10809977].
Peterson LS, Nelson AM, Su WP. Subspecialty clinics: rheumatology and dermatology. Classification of morphea (localized scleroderma). Mayo Clinic Proceedings 1995;70:1068‐76. [MedLine: 7475336].
Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmestead County 1960‐1993. Journal of Rheumatology 1997;24(1):73‐80. [MedLine: 9002014].
Rowell NR, Goodfield MD. The connective tissue diseases. Textbook of Dermatology. 5th Edition. Oxford: Blackwell Scientific Publication, 1992:2225‐3.
Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. British Journal of Rheumatology 1988;27(4):286‐90. [MedLine: 3261609].
Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether‐Beck S, et al. High‐dose UVA1 radiation therapy for localized scleroderma. Journal of the American Academy of Dermatology 1998;38(1):21‐6. [MedLine: 9204059].
Taveira M, Selores M, Costa V, Massa A. Generalized morphea and lichen sclerosus et atrophicus successfully treated with sulfasalazine. Journal of the European Academy of Dermatology and Venerology 1999;12(3):283‐4. [MedLine: 10461662].
Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Laxer RM. Localized scleroderma in childhood: a report of 30 cases. Seminars in Arthritis and Rheumatism 1994;23(5):328‐40. [MedLine: 8003062].
Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric scleroderma. Journal of Pediatrics 2000;136(1):91‐5. [MedLine: 10636981].
Wienecke R, Zochling N, Neubert U, Schlupen EM, Meurer M, Volkenandt M. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. Journal of investigative Dermatology 1994;103(1):19‐22. [MedLine: 8027576].
Wolverton SE. Comprehensive Dermatologic Drug Therapy. 1st Edition. W.B. Saunders, 2001.
Yamanaka CT, Gibbs NF. Trauma‐induced linear scleroderma. Cutis; cutaneous medicine for the practitioner 1999;63(1):29‐32. [MedLine: 9951591].
